Larotrectinib produced rapid and durable responses and a high DCR in pediatric patients with TRK fusion–positive primary central nervous system tumors.
Eftilagimod alpha plus pembrolizumb and chemotherapy generated favorable survival data in nonsquamous NSCLC.
Mark Awad, MD, PhD, and Jonathan Spicer, MD, PhD, discuss the FDA approval of perioperative nivolumab for patients with resectable NSCLC.
Janaki Neela Sharma, MD, discusses takeaways from the Sylvester Comprehensive Cancer Center 2024 Annual Oncology Update.
Investigators who champion patient-partnered cancer research have experienced challenges to their effective implementation.
This cohort study examines the risk of radiation-associated sarcoma in patients with breast cancer harboring germline TP53 variants.
The staging of small cell lung cancer significantly impacts treatment plans and potential side effects.
Physicians @OSUCCC_James are pioneering telehealth to give more patients access to lifesaving clinical trials.
An abstract is unavailable.
National Comprehensive Cancer Network updated 2 guideline resources to keep providers and other stakeholders up to date on cutting-edge genetic research.
Three Fred Hutch Cancer Center researchers received a five-year, $3.8 million award from the National Cancer Institute to delve into the “black box” of our…
